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Summary
After decades of manifold contributions aimed at defining hys-
teria, somatisation and conversion, such syndromes are still ne-
glected and their nosographical definition is debated. The DSM 
and the ICD have undergone major changes, but their clinical 
utility with regards to these syndromes is still questionable. On 
the contrary, the Diagnostic Criteria for Psychosomatic Research 
represents a useful clinical instrument since it translates psy-
chosocial variables derived from psychosomatic research into 
operational tools. The present paper offers an overview on the 
psychopathological description of syndromes such as alexithy-
mia, hypochondriasis, health anxiety, thanatophobia, conver-
sion symptoms, anniversary and reaction which are frequent in 
clinical practice, but often misdiagnosed due to their absence in 
the DSM and the ICD. In addition, the influence of culture and 
cultural changes on the modifications of psychopathological 
manifestations is described as a further possible source of mis-
diagnosing and underreporting. New psychopathologies (e.g., 
multiple chemical sensitivity, orthorexia/vigorexia) that resem-
ble conversion and/or somatisation have been developed, but 
neither is included in nosography nor taught to clinicians. The 
aim of the present paper is thus to describe psychopathologi-
cal manifestations of somatic symptoms and related disorders 
to help clinicians formulate their diagnosis on the presence of 
signs and symptoms that can be elicited during a clinical visit, 
rather than by way of exclusion of other organic or psychiatric 
disease only.
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Introduction 
Medically unexplained physical symptoms (MUPS) are 
common and account for up to three-quarters of clinical 
situations 1. The most frequent complaints mentioned by 
patients are pain, fatigue, gastrointestinal and cardiovas-
cular symptoms, and sexual and pseudo-neurological dis-
turbances. Although in most cases these conditions remit 
spontaneously  2, a small but significant proportion may 
worsen over time in terms of chronicity, severity of symp-
toms, impact on functioning, disability, development of 
medical (iatrogenic) psychiatric comorbidity and lead to 
excessive/inappropriate use of health care resources  3. 
The prevalence of such disorders ranges from 1 to 8% in 
the general adult population, with a relative risk of 2.7 
of 5-year persistence of symptoms and of 1.5 for comor-
bidity with psychiatric symptoms/disorders. They may ac-
count for a 7-fold increase in expenses for healthcare ser-
vices 4. The most complex and severe cases are character-
ised by specific clinical features, such as a high number 
of somatic symptoms, comorbidity with other psychiatric 
conditions (i.e., mainly depressive and anxiety disorders), 
presence of relevant psychosocial risk factors (e.g., histo-
ry of childhood abuse or violence) 5. On the other hand, 
the sometimes cumbersome efforts to establish valuable 
long-term clinical relationships with these patients have 
been described as a source for burnout in clinicians  6. 
Early identification of predictors for persistent, multiple 
MUPSs is crucial to help properly patients 5 who other-
wise risk to be labeled as “difficult to treat” and hence 
might develop a chronic course of illness. 
From Freud to the DSM-IV: the history  
of somatisation and conversion disorders
Somatoform disorders (SD) are often thought to be resid-
ing in a no-man’s land, in the grey area between medicine 
and psychiatry. Over the years, they have been differently 
labelled and clinicians and researchers have proposed a 
wide range of theories for their aetiology, diagnosis and 
treatment. Briquet 7 was the first who studied a syndrome 
characterised by multiple somatic symptoms and named 
it “hysteria” in 1859. Thereafter, Stekel 8 defined hysteria 
as a bodily disorder arising from the expression of a deep-
layered neurosis. Later, Lipowski’s 9 definition was: “The 
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syndrome”. In the attempt to avoid overlap with other 
diagnoses, all psychological symptoms were eliminated 
from the criteria of the DSM-III revised version  19. This 
change, which essentially separated the psychological 
dimension from the physical one, has obviously drawn 
some criticisms. Oken 20 stated that the “over reliance on 
the old biomedical model, rather than the biopsychoso-
cial model by DSM-III downplayed the benefits achieved 
by its dynamic framework comprising the psychological, 
biological and social factors”. 
Compared with DSM-III, the DSM-IV adopted a simpler 
approach, requiring a combination of pain, gastrointes-
tinal, sexual and pseudo-neurological symptoms for the 
diagnosis of somatisation disorder (SD) 21. “Undifferenti-
ated SD” refers to an array of unexplained physical symp-
toms which did not cross the threshold for full-blown 
somatisation disorder. “SD not otherwise specified” was 
kept as a residual category. BDD was added and the 
definition of conversion disorder modified. The DSM-IV 
defined “Conversion disorder” as characterized by symp-
toms affecting voluntary motor and sensory functions, in 
contrast to the DSM-III definition of any symptom sugges-
tive of a physical disorder 21. Finally, the criteria for “Pain 
disorder” were modified to include subtypes associated 
with: 1. psychological factors; 2. both psychological fac-
tors and a general medical condition; 3. a general medi-
cal condition. 
Current nosography of somatic symptoms 
According to the DSM-5, Somatic symptoms and related 
disorders (SSD) are characterised by physical symptoms 
that are very distressing or result in a significant disrup-
tion of functioning, as well as excessive and dispropor-
tionate thoughts, feelings, and behaviours regarding 
those symptoms. To satisfy such diagnoses, an individual 
must be persistently symptomatic, that is at least for 6 
months 22. SSD include “Somatic symptom disorder”, “Ill-
ness anxiety disorder”, “Conversion disorder”, “Psycho-
logical factors affecting other medical conditions”, and 
“Factitious disorder”. Compared to the previous editions 
of the DSM, several important changes have been made 
in the DSM-5; in particular, “Somatization disorder”, 
“Hypochondriasis”, “Pain disorder”, and “Undifferenti-
ated SD” have been removed. 
The DSM-IV diagnosis of “Somatization disorder” re-
quired a specific number of complaints from among 
4-symptom groups, while the SSD criteria no longer have 
such requirement, although somatic symptoms must be 
significantly distressing or disruptive to daily life and 
accompanied by excessive thoughts, feelings, or behav-
iours 22. Another important change in the DSM-5 criteria 
is that somatic symptoms do not have to be “medically 
tendency to experience, conceptualize, and/or commu-
nicate psychological states or contents as bodily sensa-
tions, functional changes or somatic metaphors”. Later, 
Lipowski placed more emphasis on “somatic distress” 
which is primarily experienced and communicated by 
these patients, rather than the “psychological distress”. 
Thus, his definition was revised into: “A tendency to ex-
perience and communicate somatic distress and symp-
toms unaccounted for by pathological findings, to attrib-
ute them to physical illness and to seek medical help for 
them” 10. This is the basic framework on which the con-
cept of hysteria has evolved over the years.
At the beginning of 1900, Janet and Freud, who had 
worked with Charcot on hypnosis  11, defined psychic 
mechanisms in the symptoms of hysteria: dissociation of 
the consciousness 12 and conversion 13. Thereafter, Freud 
and Breuer  14 proposed that mental distress might be 
“converted” into physical dysfunction. Subsequently, the 
term “conversion” was used to denote essentially func-
tional neurological disturbances. Although in their initial 
observations, both Charcot and Janet acknowledged the 
involvement of body and mind in hysteria, Janet later 
emphasised that conversion was solely mental in origin, 
thereby dismissing the role of a physical lesion hypoth-
esised by Charcot  12. Freud’s views have been reflected 
in the International Classification of Diseases (ICD) and 
in the Diagnostic and Statistical Manual of Mental Disor-
ders (DSM), in which the role of emotional conflicts – not 
necessarily accessible for patients – in generating hysteria 
is highlighted.
Morselli 15, more than a century ago, first described a case 
of body dysmorphic disorder (BDD), reporting on a young 
woman who confined herself in her apartment for 5 years, 
worrying that she would never be loved for being “ugly 
and ridiculous”. This syndrome was classified as “atypical 
somatoform disorders” in the DSM-III, before the current 
name of BDD came up in the following edition 16.
The concept of neurasthenia was defined by Beard in 
1869, who described it as “a disease of nervous system, 
without organic lesion, which may attack any or all parts 
of the nervous system, and characterized by enfeeble-
ment of the nervous force, which may have all degrees of 
severity” 17. Neurasthenia was introduced in the DSM-II to 
increase congruency with the ICD-8, but it was dropped 
from the DSM-III, although it was maintained in the ICD 
system as a subtype of neurosis.
The DSM-III derived the concept of “Somatisation dis-
order” from the criteria of “Briquet’s syndrome”, as de-
scribed and operationalised by Perley and Guze 18, who 
recognised the need to differentiate the “illness charac-
terized by multiple somatic and psychiatric complaints” 
described by Briquet from the other meanings of the 
term hysteria, and proposed the eponymous “Briquet’s 
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explained” and “psychosomatic”  24. As previously de-
scribed, the DSM-5 attempted to address this criticism by 
replacing SDs with SSD and making significant changes 
to the criteria to eliminate overlap across the somatoform 
disorders focusing on positive symptoms as well as on 
the importance of neurological examination. However, 
the DSM-5 still has a limited clinical utility due to a nar-
rowed capacity to catch the information necessary for the 
clinical process 25. 
The Diagnostic Criteria for Psychosomatic Research 
(DCPR) were introduced in 1995 to expand the tradi-
tional domains of the disease model by translating psy-
chosocial variables that derived from psychosomatic re-
search into operational tools  26. The DCPR are a set of 
12 psychosomatic syndromes whose prognostic role in 
the development, course, and outcome of physical dis-
eases, regardless of “organic” or “functional” nature, has 
been largely documented. Eight DCPR syndromes refer 
to the concept of abnormal illness behaviour: persistent 
somatisation; functional somatic symptom secondary to 
a psychiatric disorder; conversion symptoms; anniversary 
reaction; disease phobia; thanatophobia; health anxiety; 
and illness denial. The other four syndromes are alex-
ithymia, type A behaviour, demoralisation and irritable 
mood, which are related to the field of psychological fac-
tors affecting medical conditions  26-28. DCPR includes a 
semi-structured clinical interview for their assessment 27. 
These criteria were found to be more sensitive than those 
of the DSM-IV in identifying subthreshold psychological 
distress and in characterising patients’ psychological re-
sponse to medical illness 29. A recent review of the litera-
ture highlighted that the DCPR system can be clinically 
useful for subtyping medical patients, identifying sub-
threshold or undetected syndromes, evaluating the bur-
den of medical syndromes, predicting treatment outcome 
and identifying risk factors 30. 
Beyond nosography: psychopathology  
of somatic disorders 
Although neglected by DSM and ICD, several syndromes 
- which are relatively common in clinical practice - need 
to be known by clinicians. Such syndromes have been de-
scribed decades ago, but were later lost in the nomencla-
ture. Here we will describe alexithymia, hypochondriasis, 
health anxiety, thanatophobia, conversion symptoms and 
anniversary reaction as examples of somatic syndromes 
frequent in clinical practice, but often misdiagnosed due 
to their absence in the DSM and ICD. Interestingly, they 
are described and included in the DCPR which, thus, rep-
resent a useful classification system in clinical practice. 
The term alexithymia literally means “lacking words for 
feelings” and was coined to describe certain clinical char-
unexplained”, as it was for many disorders in the DSM-
IV. Furthermore, whether or not the somatic symptoms 
are medically explained, the individual would still have 
to meet the rest of the criteria to receive a diagnosis of 
SSD. However, the DSM-5 warns that it is not appropri-
ate to diagnose individuals with a mental disorder simply 
because a medical cause cannot be found. 
The DSM-IV criteria included a large number of overlap-
ping disorders and made it difficult for primary care pro-
viders to effectively isolate the problem of their patients. 
Because those suffering from SSD are primarily seen in 
general medical settings, the DSM-5 criteria tried to clar-
ify confusing terms and reduced the number of disorders 
and sub-categories to make the criteria more useful to 
non-psychiatric care providers 22. 
The ICD-10 includes somatic symptoms among neu-
rotic disorders (neurotic, stress-related and somatoform 
disorders): dissociative (conversion) disorders, somatisa-
tion disorder (including hypochondriacal disorders), and 
other neurotic disorders (among which neurasthenia) 23. 
The ICD-10 diagnosis of Somatisation Disorder differs 
from the DSM-IV for the symptom threshold and for the 
symptom duration; the DSM-IV diagnosis of BDD coin-
cides with the “Hypochondriacal disorder”; a category 
of “Somatoform autonomic disorder”, characterised by 
symptoms of autonomic arousal in the absence of any 
disturbance of structure or function, is also included 23. 
The ICD-10 criteria for “Pain disorder” require persistent, 
severe and distressing pain continuously for at least 6 
months. These symptoms, according to the ICD-10, can-
not be explained by a physical condition, omitting the 
mention of “psychological factors” categorically specified 
in the DSM-IV. Conversion disorder (conversion hysteria) 
has been renamed and conceptualised as a dissociative 
rather than a somatic disorder. Finally, differently from 
the DSM-IV, a diagnosis of “Neurasthenia” is possible in 
the category “Other neurotic disorders”. The revision of 
ICD-10 is scheduled for 2018.
Both ICD and DSM have been fully criticised for their 
poor clinical utility. Their main weaknesses are: 1) soma-
toform disorders are defined on the basis of a failure to 
find physical causes rather than on the presence of defi-
nite psychological and behavioural features; 2) there is 
a widely and commonly reported discrepancy between 
the prevalence of these disorders in clinical practice and 
the frequency of these diagnoses observed in large epide-
miologic international research; 3) the major categories 
of somatoform disorders are rare; 4) the overlap between 
somatoform disorders and depression and anxiety disor-
ders is an example of the confusion about the boundaries 
of these disorders; 5) there is evidence that many patients 
object to the explanatory basis underlying the diagnostic 
labels of somatoform disorders such as “medically un-
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notes an ill process or the condition resulting. It took, 
however, hypochondria became specifically associated 
with a morbid preoccupation over health only in nine-
teenth century. 
In 1895 Freud classified hypochondria (with neurasthe-
nia and anxiety neurosis) as an “actual neurosis”. This 
theory has never been satisfactorily explained, nor it has 
been developed by later analysts. Another approach has 
been to regard hypochondriasis as due to a disturbance 
of the body scheme or image. Fisher 37, amongst others, 
developed assessment instruments for measuring various 
aspects of this, though his whole impressive concept rests 
on the rather shaky foundations of classical psychoana-
lytical theory, projective techniques and self-report ques-
tionnaires. French authors introduced the term “coenaes-
thesiopathy”, referring to the sum of organic sensations 
which are normally vague and in the background, but 
which give a person his feeling of existence. According 
to Ey 38, hypochondriasis is a pathological form of human 
existence, and Ladee  39 gave a phenomenological exis-
tential account of hypochondriasis with the experience 
of decay as a central feature and anxiety as a frequent 
manifestation.
Although symptoms are diffuse or generalised, one par-
ticular symptom or area of concern (such as pain or dis-
turbed sleep) can present as the only complaint, and may 
occupy patient attention and dominate his life. This mon-
osymptomatic form can vary from a mild preoccupation 
to a frank delusion. If symptoms of anxiety or depression 
are present, they are minimal, atypical, difficult to detect, 
or explicable as secondary phenomena 40. Pains, particu-
larly muscular ones, are very common. Other common 
pain syndromes, which may have important psychiatric 
implications, are backache 41, atypical facial pain 42 and 
abdominal pain and right iliac fossa pain in females. In-
terestingly, Kenyon 40 also cited mental pain as a rather 
vague concept since it may mean just suffering or grief 
and be close to depression. More recently, mental pain 
has been more strictly defined as a sense of loss or in-
completeness of self and an awareness of one’s own role 
in the experience of emotional pain 43. Delusions of smell 
may be the predominant complaint, often attributed to 
the bowels and usually associated with either paranoid or 
depressive features 44. Sometimes, it is halitosis or a more 
generalised odour, perhaps in conjunction with excessive 
sweating and anxiety. Symptoms referred to the gastro-
intestinal tract are common. They can present as vague 
complaints of nausea, dysphagia, regurgitation, bad taste 
in the mouth, flatulence, or pain  45. Aerophagy can be 
an unrecognised aggravating factor. Preoccupation with 
bowel function, particularly constipation, can reach ex-
treme degrees; although in this case the correct diagnosis 
might be bowel obsession syndrome rather than hypo-
acteristics observed among patients with psychosomatic 
disorders who had difficulty engaging in insight-oriented 
psychotherapy 31. Alexithymic patients have deficiencies 
in emotional awareness and communication, and show 
little insight into their feelings, symptoms and motivation. 
When asked about their feelings in emotional situations, 
they may experience confusion (e.g., “I cannot say”), give 
vague or simple answers (e.g., “I feel down”), report bod-
ily states (e.g., “my stomach is painful”) or talk about be-
haviour (e.g., “I want to punch the table”). The alexithy-
mia construct was originally conceptualised by Nemiah, 
Freyberger and Sifneos  32 as encompassing a cluster of 
cognitive traits including difficulties in identifying feel-
ings and describing feelings to others, externally oriented 
thinking and limited imaginal capacity. The alternative 
conceptualisation proposed by Lane and co-workers  33 
– alexithymia as a global impairment in emotional pro-
cessing resulting in limited emotional expression and 
recognition – has been less influential. Both definitions 
agree that alexithymia is a deficit, inability, or deficiency 
in emotional processing rather than a defensive process, 
and this deficit view is gaining increasing support from 
basic laboratory and neuroimaging research 34.
Alexithymia was first described in people with psychoso-
matic disorders, and subsequent research has confirmed 
elevated levels of alexithymia in people with rheumatoid 
arthritis, essential hypertension, peptic ulcer and inflam-
matory bowel disease 35. Yet, studies have found elevated 
levels of alexithymia in patients with several other con-
ditions (e.g. cardiac disease, non-cardiac chest pain, 
breast cancer, diabetes, chronic pain, eating disorders, 
substance dependence, kidney failure, stroke, HIV infec-
tion, fibromyalgia) 36. The growing recognition that alex-
ithymia is not specific to psychosomatic disorders has led 
to the view of alexithymia as a risk factor for medical, 
psychiatric, or behavioural problems that are influenced 
by disordered affect regulation. Indeed, alexithymia has 
been associated with failure to use adaptive affect regula-
tion processes such as modulating arousal, appropriately 
expressing or suppressing emotions, employing fantasy, 
obtaining and using social support, tolerating painful 
emotions, cognitive assimilation and accommodation. 
Hypochondrium is the uppermost part of the abdomen. 
The word derives from the Greek term hypokhondrios, 
which literally means “of the soft parts between the ribs 
and navel”, from hypo (“under”) and khondros, or carti-
lage (of the sternum). Hypochondria in Latin means “the 
abdomen”. 
This transference of meaning paralleled changing con-
cepts of pathology, especially in relation to the four hu-
mors, until ultimately various mental states came to be 
associated with changes in the organs of the hypochon-
dria, notably the spleen and the liver. The suffix -iasis de-
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sion symptoms are relatively persistent losses or alterations 
in sensory or voluntary motor functioning that cannot be 
explained by known physical disorders or pathophysi-
ologic mechanisms. Examples include paralysis, abnormal 
movements, aphonia, hypoesthesia, sensations of coldness 
or warmth, blindness and deafness. A conversion symptom 
can occur alone, as part of another psychiatric disorder, or 
as part of a medical or neurologic disorder. 
“Anniversary reaction” was first introduced by Hilgard in 
1953  56 to describe the appearance of psychotic symp-
toms in a woman when her daughter reached the age 
she had been when her own father died. Thereafter, an-
niversary reaction was described as an emotional, physi-
cal and/or behavioural response triggered by emotionally 
burdened dates or times  57. In the DCPR, anniversary 
reaction is defined as a special form of somatisation or 
conversion and frequently occurs together with other 
psychosomatic syndromes 28.
According to the DCPR, other psychosomatic syndromes 
are noteworthy: persistent somatisation, functional so-
matic symptoms secondary to a psychiatric disorder, ill-
ness denial, “Type A behaviour” and demoralisation 26-28. 
Hysteria in the 2000s
Culture and cultural changes deeply affect the way peo-
ple experience and express their suffering; this is why 
psychopathology changes over time  58. An example of 
this phenomenon is the argument supported by Engel 59 
who suggested that the bio-medical model had become a 
“folk model”, with many consequences on clinical pres-
entations of suffering and health care service provision 
and organisation. Indeed, culture and psychosomatic 
medicine are so strongly interrelated to become inex-
tricable. This becomes particularly evident for disorders 
such as somatisation and conversion, due to their com-
plex, predominantly functional pathogenesis, which can 
only be understood and dealt with assuming a bio-psy-
cho-social perspective. 
Hysterical expressions of distress have been conceived as 
psychodynamically less evolved, or more regressive, than 
explicit, direct, psychological manifestations. With refer-
ence to this, and to the solid interconnection between 
culture and psychopathology, the study of psychosomatic 
presentations of distress in a cross-cultural perspective has 
contributed significantly to a more critical understanding 
of the deep psychopathological meaning of somatisation 
and conversion, which were effectively defined as “the 
black box” of psychopathology 60. Although large epidemi-
ological studies confirmed that MUPS are similarly vague 
worldwide and not associated with ethnicity  61, the psy-
chopathology of these clinical manifestations should still 
be analysed under a cultural perspective. Kirmayer and 
chondriasis  46. It is sometimes difficult to prevent these 
patients from undergoing repeated investigations or un-
necessary surgical procedures. Many anxious and intro-
spective patients complain of palpitations or missing a 
beat. They sometimes have vague ideas that they have 
a “tired heart”. Patients may also experience a type of 
inspirational dyspnoea with a feeling that they can never 
take a really deep and satisfying breath. Some patients 
are constantly preoccupied with poor hearing which they 
attribute to “wax”, and may spend a lot of time picking at 
the external auditory meatus or putting in various drops. 
Others complain of dizziness, vertigo, tinnitus, hearing 
their pulse beat at night, or general hyperacusis. Nebu-
lous complaints of sinusitis or recurrent sore throats may 
be met. The feeling of a lump in the throat or globus hys-
tericus may be organically determined 47. Irritating hab-
its, such as constant sniffing, clearing the throat or cough 
may be present. A common complaint regarding vision is 
of “floaters” (muscae volitantes) 40.
Disease phobia, thanatophobia and health anxiety may 
be part of a hypochondriacal syndrome, yet they may 
also occur in the absence of other psychiatric disorders. 
Disease phobia was first described by Bianchi 48 as “a per-
sistent, unfounded fear of suffering from a disease, with 
some doubt remaining despite examination and reassur-
ance”, and Ryle 49 added that it includes also the fear of 
inheriting or acquiring a disease. According to Fava and 
Grandi  50, disease phobia differs from hypochondriasis 
for two characteristics: specificity and longitudinal stabil-
ity (fears concern a specific disease and are unlikely to 
be moved on another disease or organ system), phobic 
quality (fears tend to manifest themselves in attacks rather 
than in constant worries as in hypochondriasis). Noyes 
et al. 51 also pointed out that disease phobia often results 
in the avoidance of internal and external illness-related 
stimuli, while hypochondriasis usually leads to reassur-
ance-seeking or checking behaviours. 
Thanatophobia was described for the first time by Ryle in 
1928 52 as a sense of dying (“angor animi”). It consists of 
a sudden sense and/or conviction of being on the point 
of dying without any medical reasons, and may result in 
the avoidance of stimuli concerning death (e.g., obituary 
notices, funerals) 53.
Health anxiety includes a variety of worries and attitudes 
concerning illness and pain, which are less specific than 
hypochondriasis and disease phobia. Health anxiety differs 
from hypochondriasis since the former responds to medi-
cal reassurance, whereas worries about health may ensue 
after reassurance in the latter, leading patients to new body-
checking behaviours and medical examinations 50. 
Conversion symptoms were defined by Engel 54 as ambiva-
lence in symptoms reporting or history of similar symptoms 
wished on someone else. Lazare 55 observed that conver-
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illnesses, but advances in psychosomatic medicine have 
contributed to the understanding of complex aetio-path-
ological pathways and disentangle the interrelationship 
between health and culture, opening the way to new and 
effective therapeutic strategies. New challenges, and new 
opportunities, in diagnosis, clinical management and 
therapy have been proposed 66. Innovative organizational 
care models, based on trans-disciplinarity are needed. 
Interesting tools for the assessment of bio-psycho-social 
complexity are the INTERMED method by Wild and co-
workers 67 and the already mentioned DCPR 26. 
Conclusions 
In 1960, G. Engel  68 criticised the concept of disease: 
“The traditional attitude toward disease tends in practice 
to restrict what it categorizes as disease to what can be 
understood or recognized by the physician and/or what 
he notes can be helped by this intervention. This attitude 
has plagued medicine throughout its history and still 
stands in the way physicians fully appreciating disease as 
a natural phenomenon”. The inadequacy of the concept 
of disease particularly applies to medical symptoms that 
are not explained by organic disease or abnormal labora-
tory testing. Such symptoms may be transient without re-
quiring medical attention, or may be a cause of concern, 
disability and excessive healthcare costs 69. These symp-
toms can be attributed to somatisation, defined by Lip-
owski 70 as the tendency to experience and communicate 
psychological distress in the form of physical symptoms 
and to seek medical help for them. Anything that cannot 
be explained by organic factors, with special reference 
to laboratory investigations, is thus likely to fall within 
the domains of somatisation. The DSM-IV represented 
the effort of classifying such symptoms according to their 
clustering and characteristics. The DSM-5 emphasises 
diagnosis made on the basis of positive signs and symp-
toms rather than the absence of a medical explanation 
for somatic symptoms. However, the DSM-5 maintains 
the old logic that if it is not organic, it is psychiatric. In 
this review, we have tried to describe somatic disorders 
on the basis of their psychopathological manifestations 
rather than on the basis of the traditional nosography, 
with the specific aim to give clinicians useful tools to ob-
tain a correct diagnosis, and not to reach it via a long 
way encompassing the exclusion of any other organic or 
psychiatric disorder. 
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